{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:13:56Z","timestamp":1783566836720,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism Open"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.metop.2020.100052","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T02:51:58Z","timestamp":1597719118000},"page":"100052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Renin-Angiotensin System overactivation in polycystic ovary syndrome, a risk for SARS-CoV-2 infection?"],"prefix":"10.1016","volume":"7","author":[{"given":"Abu Saleh Md","family":"Moin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thozhukat","family":"Sathyapalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Atkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra E.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.metop.2020.100052_bib1","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00125-011-2398-8","article-title":"Reno-protective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis","volume":"55","author":"Vejakama","year":"2012","journal-title":"Diabetologia"},{"issue":"2A","key":"10.1016\/j.metop.2020.100052_bib2","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1016\/S0002-9149(01)02321-9","article-title":"The role of the renin-angiotensin system in the development of cardiovascular disease","volume":"89","author":"Unger","year":"2002","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.metop.2020.100052_bib3","doi-asserted-by":"crossref","first-page":"H1219","DOI":"10.1152\/ajpheart.00796.2011","article-title":"The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome","volume":"302","author":"Putnam","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.metop.2020.100052_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1467-789X.2003.00091.x","article-title":"Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders","volume":"4","author":"Goossens","year":"2003","journal-title":"Obes Rev"},{"issue":"4","key":"10.1016\/j.metop.2020.100052_bib5","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/01.ASN.0000060804.40201.6E","article-title":"Mechanism of increased angiotensin II levels in glomerular mesangial cells cultured in high glucose","volume":"14","author":"Singh","year":"2003","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.metop.2020.100052_bib6","doi-asserted-by":"crossref","first-page":"H939","DOI":"10.1152\/ajpheart.00391.2007","article-title":"High-glucose-induced regulation of intracellular ANG II synthesis and nuclear redistribution in cardiac myocytes","volume":"293","author":"Singh","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"12","key":"10.1016\/j.metop.2020.100052_bib7","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.2337\/db08-0805","article-title":"Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis","volume":"57","author":"Singh","year":"2008","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.metop.2020.100052_bib8","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.2337\/db11-1824","article-title":"Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKCbeta activation in diabetes","volume":"61","author":"Mima","year":"2012","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.metop.2020.100052_bib9","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1210\/endo.141.12.7844","article-title":"High levels of glucose stimulate angiotensinogen gene expression via the P38 mitogen-activated protein kinase pathway in rat kidney proximal tubular cells","volume":"141","author":"Zhang","year":"2000","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.metop.2020.100052_bib10","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1523-1755.1999.00271.x","article-title":"Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells","volume":"55","author":"Zhang","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.metop.2020.100052_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fendo.2014.00023","article-title":"Tissue Renin-Angiotensin systems: a unifying hypothesis of metabolic disease","volume":"5","author":"Skov","year":"2014","journal-title":"Front Endocrinol"},{"issue":"43","key":"10.1016\/j.metop.2020.100052_bib12","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A\u00a0human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.metop.2020.100052_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/1042517021000021608","article-title":"Molecular cloning, mRNA expression and chromosomal localization of mouse angiotensin-converting enzyme-related carboxypeptidase (mACE 2)","volume":"13","author":"Komatsu","year":"2002","journal-title":"DNA Seq"},{"issue":"5","key":"10.1016\/j.metop.2020.100052_bib14","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A\u00a0novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ Res"},{"issue":"17","key":"10.1016\/j.metop.2020.100052_bib15","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J\u00a0Biol Chem"},{"issue":"14","key":"10.1016\/j.metop.2020.100052_bib16","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.metop.2020.100052_bib17","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.108.184911","article-title":"Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart","volume":"103","author":"Mercure","year":"2008","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.metop.2020.100052_bib18","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.2337\/db09-0782","article-title":"Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice","volume":"59","author":"Bindom","year":"2010","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.metop.2020.100052_bib19","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/iub.1190","article-title":"Angiotensin converting enzyme 2: a new important player in the regulation of glycemia","volume":"65","author":"Chhabra","year":"2013","journal-title":"IUBMB Life"},{"issue":"4","key":"10.1016\/j.metop.2020.100052_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062833","article-title":"Rosiglitazone treatment of type 2 diabetic db\/db mice attenuates urinary albumin and angiotensin converting enzyme 2 excretion","volume":"8","author":"Chodavarapu","year":"2013","journal-title":"PloS One"},{"issue":"1\u20133","key":"10.1016\/j.metop.2020.100052_bib21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.regpep.2012.05.093","article-title":"Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction","volume":"177","author":"Murca","year":"2012","journal-title":"Regul Pept"},{"issue":"11","key":"10.1016\/j.metop.2020.100052_bib22","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1089\/hum.2009.160","article-title":"ACE2 overexpression ameliorates left ventricular remodeling and dysfunction in a rat model of myocardial infarction","volume":"21","author":"Zhao","year":"2010","journal-title":"Hum Gene Ther"},{"issue":"2","key":"10.1016\/j.metop.2020.100052_bib23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2337\/db09-1218","article-title":"Human recombinant ACE2 reduces the progression of diabetic nephropathy","volume":"59","author":"Oudit","year":"2010","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.metop.2020.100052_bib24","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1113\/expphysiol.2011.058578","article-title":"Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke","volume":"96","author":"Mecca","year":"2011","journal-title":"Exp Physiol"},{"issue":"4","key":"10.1016\/j.metop.2020.100052_bib25","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.2337\/db12-0808","article-title":"Activation of the ACE2\/angiotensin-(1-7)\/Mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitors","volume":"62","author":"Jarajapu","year":"2013","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.metop.2020.100052_bib26","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jacc.2005.05.051","article-title":"Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials","volume":"46","author":"Abuissa","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.metop.2020.100052_bib27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2337\/diacare.27.1.247","article-title":"Antihypertensive therapy and incidence of type 2 diabetes: a systematic review","volume":"27","author":"Padwal","year":"2004","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.metop.2020.100052_bib28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/HYPERTENSIONAHA.112.191452","article-title":"Possible involvement of angiotensin-converting enzyme 2 and Mas activation in inhibitory effects of angiotensin II Type 1 receptor blockade on vascular remodeling","volume":"60","author":"Iwai","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.metop.2020.100052_bib29","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.metop.2020.100052_bib30","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention","volume":"323","author":"Wu","year":"2020","journal-title":"Jama"},{"issue":"5","key":"10.1016\/j.metop.2020.100052_bib31","doi-asserted-by":"crossref","first-page":"P475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.metop.2020.100052_bib32","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1464-5491.2006.01861.x","article-title":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS","volume":"23","author":"Yang","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/j.metop.2020.100052_bib33","series-title":"Hypermetabolism in critically ill patients with COVID-19 and the effects of hypothermia: a case series","author":"Yu","year":"2020"},{"issue":"6","key":"10.1016\/j.metop.2020.100052_bib34","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"issue":"7","key":"10.1016\/j.metop.2020.100052_bib35","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","article-title":"Obesity and the polycystic ovary syndrome","volume":"26","author":"Gambineri","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"9","key":"10.1016\/j.metop.2020.100052_bib36","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.2337\/db11-1360","article-title":"Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study","volume":"61","author":"Gambineri","year":"2012","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.metop.2020.100052_bib37","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12916-020-01697-5","article-title":"Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic","volume":"18","author":"Kyrou","year":"2020","journal-title":"BMC Med"},{"issue":"2","key":"10.1016\/j.metop.2020.100052_bib38","doi-asserted-by":"crossref","first-page":"100113","DOI":"10.1016\/j.ajogmf.2020.100113","article-title":"Two cases of coronavirus 2019-related cardiomyopathy in pregnancy","volume":"2","author":"Juusela","year":"2020","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"1","key":"10.1016\/j.metop.2020.100052_bib39","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1038\/s41598-020-61531-z","article-title":"Effect of induced hypoglycemia on inflammation and oxidative stress in type 2 diabetes and control subjects","volume":"10","author":"Kahal","year":"2020","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.metop.2020.100052_bib40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.coph.2006.03.001","article-title":"Angiotensin-converting enzyme 2 in lung diseases","volume":"6","author":"Kuba","year":"2006","journal-title":"Curr Opin Pharmacol"},{"issue":"12","key":"10.1016\/j.metop.2020.100052_bib41","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1210\/me.2013-1098","article-title":"Androgen regulation of the TMPRSS2 gene and the effect of a SNP in an androgen response element","volume":"27","author":"Clinckemalie","year":"2013","journal-title":"Mol Endocrinol"}],"container-title":["Metabolism Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589936820300323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589936820300323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:55:31Z","timestamp":1762905331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589936820300323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":41,"alternative-id":["S2589936820300323"],"URL":"https:\/\/doi.org\/10.1016\/j.metop.2020.100052","relation":{},"ISSN":["2589-9368"],"issn-type":[{"value":"2589-9368","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renin-Angiotensin System overactivation in polycystic ovary syndrome, a risk for SARS-CoV-2 infection?","name":"articletitle","label":"Article Title"},{"value":"Metabolism Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metop.2020.100052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100052"}}